More News! For those who want to keep up with everything

mission therapeutics abbvie parkinsons disease

More News! 16 Nov 2018

AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease

The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to treat the neurodegenerative conditions Alzheimer’s disease and Parkinson’s disease. The new collaboration aims to fund the preclinical development of drugs that inhibit proteins called deubiquitinating enzymes. Deubiquitinating enzymes modify proteins in the cell, controlling essential functions such as what the […]

November 16, 2018 - 2 minutesmins - By Jonathan Smith

More News! 15 Nov 2018

Soldier Bug Could Help Combat Antibiotic Resistance

A garden insect makes a molecule that attacks the cell wall of bacteria, providing a new potential weapon in the fight against antibiotic resistance. Thanatin is a peptide molecule produced by the spined soldier bug Podisus maculiventris to control the types of bacteria that live in its gut. A research group from the University of Zurich […]

November 15, 2018 - 2 minutesmins - By Jonathan Smith

More News! 13 Nov 2018

French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins

The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the brain to lower blood pressure. A Phase IIb trial, run by Quantum Genomics, found that eight weeks of taking its drug significantly lowered blood pressure in patients who were overweight or obese and with high blood pressure. This reduction also […]

November 13, 2018 - 2 minutesmins - By Jonathan Smith

More News! 12 Nov 2018

This UK Biotech Wants to Make Antibodies Easy to Swallow

Say goodbye to painful antibody injections. The UK biotech Intract Pharma has received a €1.6M grant to advance oral immunotherapy based on approved antibodies, causing less discomfort for patients. The grant, awarded by public agency Innovate UK, will help Intract develop oral versions of existing antibody therapies. This could make the treatments easier for patients […]

November 12, 2018 - 2 minutesmins - By Jonathan Smith

More News! 30 Oct 2018

British Diagnostics Firm Develops More Accurate Fetal Health Screen

A lab kit from British diagnostics company Angle could make non-invasive fetal health screens more accurate by analyzing whole fetal cells in the mother’s blood. To screen your unborn baby for genetic conditions, the most accurate current option is invasive techniques such as amniocentesis. These techniques take samples directly from the womb that contain fetal […]

October 30, 2018 - 2 minutesmins - By Jonathan Smith

More News! 29 Oct 2018

Plasma Replacement Therapy Promising in Alzheimer’s Patients

A blood plasma replacement therapy from Spanish company Grifols reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo. The researchers monitored the cognitive symptoms of 496 patients with Alzheimer’s disease in the Phase IIb/III trial. Over 14 months, the therapy had no effect in patients with mild Alzheimer’s, but the […]

October 29, 2018 - 2 minutesmins - By Jonathan Smith

More News! 18 Oct 2018

Phase III Triumph for Topical Hormonal Acne Treatment

The Italian biotech Cassiopea reports good news for acne sufferers. Its hormonal anti-acne treatment Winlevi significantly helped to reduce acne in two Phase III trials. Winlevi, when applied to the skin, cleared the acne in more than twice as many participants with moderate or severe acne as placebo. The treatment also showed good safety results […]

October 18, 2018 - 2 minutesmins - By Jonathan Smith

More News! 17 Oct 2018

The EU Patent of the Best Selling Drug Has Expired, What Does it Mean for Biotech?

AbbVie’s Humira, a treatment for inflammatory disease and the world’s best-selling drug, is no longer patent-protected in the EU. Competitors are already taking advantage of it. Humira is an antibody drug, called adalimumab, that has been topping the lists of best-selling drugs for years. Last year alone, it made over €15B in sales worldwide. The […]

October 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 16 Oct 2018

Drug Combination for Rare Genetic Nerve Disorder Nails Phase III

A treatment developed by French biotech Pharnext has become the first clinically proven therapy for a rare genetic disorder that affects the nervous system. In a Phase III trial, the treatment reduced the level of disability of patients with Charcot-Marie-Tooth disease, a condition that affects peripheral nerves. This disease causes problems with walking, running and […]

October 16, 2018 - 2 minutesmins - By Jonathan Smith

More News! 14 Oct 2018

Living Instruments: Making Music with Yeast, Moss and Paramecia

These instruments are alive. Yeast, moss and paramecia are behind the unique sounds of Living Instruments, which will be performing a concert in Zurich on October 21st. Instead of strings or windpipes, the sounds of these instruments are generated by living beings. The sound of the ‘yeast organ’ is triggered by the bubbles produced by […]

October 14, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

European Commission bioeconomy header e1573473988265

More News! 12 Oct 2018

European Commission Updates Strategy to Energize Europe’s Bioeconomy

In challenging times of climate change and a scarcity of resources, the European Commission has released a new strategy to boost activity and investment in companies contributing to the bioeconomy. As one of the key economies that signed the Paris Agreement in 2015, the EU aims to cut greenhouse gas emissions by at least 40% […]

October 12, 2018 - 2 minutesmins - By Jonathan Smith

More News! 10 Oct 2018

This Test Can Detect Four Drugs With Just a Fingerprint

The British company Intelligent Fingerprinting has shown that its non-invasive fingerprint drug test can yield results comparable to blood tests in just 10 minutes. The technology, developed at the University of East Anglia, can detect extremely low amounts of amphetamines, cannabis, cocaine and opiate drugs from the sweat of a single fingerprint. The sample is […]

October 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us